BAX
BAXTER INTERNATIONAL INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$27.01
+5.94%Next report
Analyst consensus
- Next report date
- Feb 11, 2027
- EPS estimate
- $0.59
- Revenue estimate
- $3.0B
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- $0.58
- EPS estimate
- $0.52
- Revenue actual
- $3.0B
- Revenue estimate
- $2.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +15.9%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $24
- PT range
- $20 – $27
- Analysts
- 4
0 Buy3 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | $0.52 | $0.58 | Beat 11.75% | $3.0B |
| Jul 30, 2026 | $0.37 | $0.56 | Beat 52.80% | $3.0B |
| Apr 30, 2026 | $0.31 | $0.36 | Beat 16.13% | $2.7B |
| Feb 12, 2026 | $0.53 | $0.44 | Miss -16.98% | $3.0B |
| Oct 30, 2025 | $0.60 | $0.69 | Beat 15.00% | $2.8B |
| Jul 31, 2025 | $0.60 | $0.59 | Miss -1.67% | $2.8B |
| May 1, 2025 | $0.48 | $0.55 | Beat 13.75% | $2.6B |
| Feb 20, 2025 | $0.53 | $0.58 | Beat 9.85% | $10.6B |
| Nov 8, 2024 | $0.78 | $0.80 | Beat 2.56% | $2.7B |
| May 2, 2024 | $0.60 | $0.65 | Beat 7.62% | $3.6B |
| Feb 8, 2024 | $0.86 | $0.88 | Beat 2.80% | $3.9B |
| Nov 2, 2023 | $0.66 | $0.68 | Beat 3.19% | $3.7B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 11, 2027